China Journal of Chinese Materia Medica 2012-12-01

[Advance in latest studies on pharmacological effects of magnolol].

Yong Zhang, Fang Tang

Index: Zhongguo Zhong Yao Za Zhi 37(23) , 3526-30, (2012)

Full Text: HTML

Abstract

Magnolol is one of main active constituents from Magnolia officinalis, a widely used traditional Chinese medicine. Previous studies have proved its multiple pharmacological effects, such as anti-oxidation, anti-microbial and anti-tumor. In recent years, more and more studies have focused on magnolol both at home and abroad. This essay summarizes the advance in the latest studies on the pharmacological effects of magnolol, and briefs main problems in current studies and future development orientation.

Related Compounds

  • Magnolol

Related Articles:

Regio- and isoform-specific glucuronidation of psoralidin: evaluation of 3-o-glucuronidation as a functional marker for UGT1A9.

2015-07-01

[J. Pharm. Sci. 104 , 2369-77, (2015)]

Resuscitation from experimental traumatic brain injury by magnolol therapy.

2013-10-01

[J. Surg. Res. 184(2) , 1045-52, (2013)]

Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway.

2015-10-01

[Cancer Sci. 106 , 1341-50, (2015)]

Magnolol induces apoptosis in MCF-7 human breast cancer cells through G2/M phase arrest and caspase-independent pathway.

2013-09-01

[Pharmazie 68(9) , 755-62, (2013)]

Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders.

2010-09-01

[Molecules 15(9) , 6452-65, (2010)]

More Articles...